
CAS 2070014-87-6
:MRT68921 HCl
Description:
MRT68921 HCl, with the CAS number 2070014-87-6, is a chemical compound that belongs to the class of small molecule inhibitors. It is primarily recognized for its role as a selective inhibitor of certain kinases, particularly those involved in cellular signaling pathways. This compound has garnered attention in the field of medicinal chemistry and drug development due to its potential therapeutic applications, particularly in oncology and other diseases characterized by dysregulated kinase activity. MRT68921 HCl is typically characterized by its hydrochloride salt form, which enhances its solubility in aqueous solutions, making it suitable for biological assays. The compound's structure features specific functional groups that contribute to its binding affinity and selectivity towards target kinases. In laboratory settings, MRT68921 HCl is often utilized in research to elucidate the mechanisms of kinase signaling and to explore its efficacy in inhibiting tumor growth in various cancer models. As with many chemical substances, proper handling and safety precautions are essential when working with MRT68921 HCl in research environments.
Formula:C25H35ClN6O
Synonyms:- N-(3-((5-Cyclopropyl-2-((2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)amino)pyrimidin-4-yl)amino)propyl)cyclobutanecarboxamide hydrochloride
- MRT68921 HCl,MRT-68921 HCl
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
N-(3-((5-Cyclopropyl-2-((2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)amino)pyrimidin-4-yl)amino)propyl)cyclobutanecarboxamide hydrochloride
CAS:Formula:C25H35ClN6OPurity:95%Color and Shape:SolidMolecular weight:471.038MRT68921 HCl
CAS:<p>MRT68921 hydrochloride is a potent inhibitor of both ULK1 and ULK2 (IC50s: 2.9 and 1.1 nM, respectively).</p>Formula:C25H34N6O·HClPurity:99.86% - 99.98%Color and Shape:SolidMolecular weight:471.04N-(3-((5-Cyclopropyl-2-((2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)amino)pyrimidin-4-yl)amino)propyl)cyclobutanecarboxamide hydroc hloride
CAS:<p>N-(3-((5-Cyclopropyl-2-((2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)amino)pyrimidin-4-yl)amino)propyl)cyclobutanecarboxamide hydrochloride is a potent and selective kinase inhibitor, which is a synthetic small molecule. Its design leverages structure-based drug design methodologies to achieve high specificity toward targeted kinases implicated in oncogenic signaling pathways. By selectively antagonizing these kinases, the compound disrupts the phosphorylation cascade essential for tumor cell proliferation and survival.</p>Formula:C25H35ClN6OPurity:Min. 95%Molecular weight:471 g/mol




